Kintsugi

Company profile

About Kintsugi

Kintsugi is a mental health technology company that leverages voice biomarker AI to identify, triage, and facilitate care for depression and anxiety. The company's flagship product, Kintsugi Voice, analyzes acoustic features of speech—including pitch, intonation, tone, and pauses—to detect signs of mental health conditions without relying on what is said, making it language-agnostic and privacy-preserving. The platform integrates seamlessly into existing clinical workflows, call centers, and telehealth systems through an API-first approach, enabling real-time screening and triage. Kintsugi's mission is to scale access to mental healthcare for all, addressing the critical gap where 60% of patients with mental health conditions fall through the cracks and 30-40% remain undiagnosed. The company recognizes that clinical depression is present in 80% of chronic health conditions and that undiagnosed depression increases healthcare costs by 2-8 times. By providing objective, quantifiable mental health screening tools, Kintsugi helps clinicians who currently only note mental health conditions 33.6% of the time according to a global Lancet study. The company offers three complementary products: Kintsugi Voice for enterprise identification and triage, Kintsugi Connect for routing individuals to appropriate mental health resources, and the Kintsugi App for personal voice journaling and self-care. Kintsugi works with payers, health systems, providers, and digital health companies to improve member outcomes, close care gaps, and reduce costs through early detection and intervention. The company has published peer-reviewed research in the Annals of Family Medicine and has been recognized by Gartner as a Cool Vendor in AI Governance and Responsible AI, and by CB Insights as one of the Digital Health 150.

Company description · Kintsugi official website